Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets , Volume 4 - Number 6

Nerve Growth Factor Receptors and Signaling in Breast Cancer

, 4(6): 463 - 470

Laurent Dolle, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe and Hubert Hondermarck

DOI: 10.2174/1568009043332853

Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

, 4(6): 471 - 482

E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis

DOI: 10.2174/1568009043332835

Mammaglobin-Based Strategies for Treatment of Breast Cancer

, 4(6): 531 - 542

Peter S. Goedegebuure, Mark A. Watson, Carsten T. Viehl and Timothy P. Fleming

DOI: 10.2174/1568009043332862


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog